Ajanta Pharma Limited rises 11% in Q3 and its profit Rises 61%:
The Ajanta Pharma Limited announced the Dec quarter report with a high set of numbers on 5th Feb. After that, the company surged 11% on Feb 6. By the ending of Dec 2019, the net profit of the company reached Rs 108 cr with a growth of 61% in a year. Comparatively, the company reported the profit of the company at Rs 67 cr in the last year’s same period.
This year, the company’s revenue raised by 34% and reached Rs 651 cr. Also, the EBITDA raised to Rs 186 cr with a growth of 73% in a year.
in 9 months, the revenue of the company reached Rs 1,906 cr with 24% of growth, from last year’s revenue of Rs 1,540 cr. The EBITDA stood at Rs 540 cr with a 25% growth from Rs 431 cr in a year. Moreover, in the 3rd quarter, the PAT or net profit increased from Rs 298 cr to Rs 339 cr with 14% growth.
In this Dec quarter, India sales grew 12% in a year and stood at Rs 195 cr. The expenditure on research and development is Rs 35 cr, said by the company. Similarly, from the last 9 months, the expenditure of R&D reached to Rs 114 cr.
The company’s EPS increased from Rs 7.60 to Rs 12.32 per eq share in a year. Ajanta Pharma Ltd shares trading with a gain of 108.90 points reached 1,306.00 INR with a 9.10% rise. Its previous close at 398.70 INR. Ajanta Pharma Ltd Share outstanding with 87,700,000. The IPO listing on the Bombay Stock Exchange.
